Concentration use ranges from 0.1-1.0% depending on the formula
The "maintained improvements" group (approximately 30-40% of users) reports substantial benefit retention 6-12 months post-discontinuation, typically characterized by users who completed 6+ month treatment courses using adequate concentrations (1-2% GHK-Cu), maintained consistent application patterns, addressed underlying skin damage during treatment allowing structural improvements, optimized complementary skincare including sun protection and moisturization, maintained healthy lifestyle supporting collagen synthesis including adequate protein intake and sleep, and possessed favorable genetics for collagen production and skin aging resistance
Retrieved 19 January 2023
[354] It's important to note that participants in these trials will continue to receive their regular intraocular pressure-lowering glaucoma medications alongside these investigational interventions
We serve clients from Catonsville MD, Ellicott City MD, Columbia MD, Baltimore MD, Pikesville MD, and surrounding areas